Novo Nordisk A/S (NVO)

45.76 +0.89 (+1.98%) USD  |  NYSE  |  May 06, 16:00
46.11 +0.35 (+0.76%) Pre-Market: 06:31
More

Novo Nordisk Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Evaxion AS Upgrade
Ascendis Pharma A/S Upgrade
Prothena Corp. Plc Upgrade
Viking Therapeutics, Inc. Upgrade
Cellectis SA Upgrade